Ping An Insurance Adds AI Coach to Health Longevity System
Ping An Insurance has upgraded its health longevity service system, launched an AI and human coaching service, and unveiled 11 health longevity centers across China.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Ping An Insurance has upgraded its health longevity service system, launched an AI and human coaching service, and unveiled 11 health longevity centers across China.
Akido is expanding ScopeAI across 100 clinics, virtual care, and field medicine services, with access to 1 million patients in California, New York City, and Rhode Island.
Stellarus launched CSR Chat, an AI powered copilot that gives health plan customer service representatives guidance, policy information, and suggested responses during member and provider interactions.
Ensora Health has launched Ensai, an AI system for TheraNest and Fusion that drafts session notes, improves clinician written notes, and answers product support questions.
Andor Health says CMS recognized ThinkAndor for reaching General Availability in the CMS Health Technology Ecosystem initiative, covering patient facing AI capabilities already used across 40 health systems.
Proteotype Diagnostics unveiled Alchemi, a data and clinical workflow platform for its investigational Enlighten cancer blood test. The 15 month program starts September 1, 2026, with about €499,000 from the European Innovation Council.
Dasher Neuroscience has completed recruitment of 90 patients for a global Phase 2 trial of YA-101 in multiple system atrophy. The company expects top line clinical data in the first quarter of 2027.
A Samsung Medical Center study presented at ADLM 2026 found ML may improve interpretation of plasma free metanephrine tests for PPGL, but later analysis showed shortcut learning affected the results.
RWJBarnabas Health and Rutgers University researchers found that an AI early warning system helped detect clinical decline earlier in hospitalized patients. The study found deaths among high risk patients fell from 23.1 percent to 18.6 percent after implementation.
Ultima Genomics and BaseClear announced that BaseClear has adopted Ultima's UG200 Platform and will offer sequencing services in Europe and globally. BaseClear is the first Ultima Certified Service Provider in Europe.
AssureCare and CURIS have partnered to help Federally Qualified Health Centers and rural clinics use CMS Rural Health Transformation funding for care management, patient engagement, analytics, and nutrition management.
Redox and Lapsi Health are collaborating to integrate the Keikku Clinical Platform with existing EHR systems through Redox's healthcare data network.
Natural Cycles has received its sixth FDA clearance for its next generation AI powered NC° Fertility Algorithm. The update uses statistical modeling and machine learning to adapt fertility predictions to individual cycle patterns.
Insilico Medicine will present first in human Phase 1 data for ISM6331 at ESMO Congress 2026 in Madrid.
Care Career has acquired MAS Medical Staffing, its seventh acquisition in 24 months. The deal adds MAS Medical Staffing's clinician network, client relationships, and MAESTRA engagement technology to Care Career's AI powered workforce platform.
MindWalk Holdings gave the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, at AMD's Advancing AI 2026 event in San Francisco.
Orbiva, a Home Control International subsidiary, signed an MOU with Indonesia's Articura to explore healthcare AI infrastructure and digital health tools for local hospitals and clinics.
VELMENI has received FDA 510(k) clearance for VELMENI for DENTISTS 3D, software that uses AI to assist dental professionals with CBCT scan review and analysis.
Cognizant and Gulf Edge Company Limited have formed a strategic partnership to deliver AI services across Thailand, with an initial focus on banking, energy, healthcare, telecom, manufacturing, and the public sector.
DarioHealth Corp. announced the pricing of a $23.5 million registered direct offering of common stock, with shares priced at $6.80 each. The offering is expected to close on or about July 23, 2026, subject to customary conditions.